Literature DB >> 19665245

Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cells.

Stephanie Hehlgans1, Iris Eke, Katja Storch, Michael Haase, Gustavo B Baretton, Nils Cordes.   

Abstract

BACKGROUND AND
PURPOSE: Resistance of pancreatic ductal adenocarcinoma (PDAC) to chemo- and radiotherapy is a major obstacle. The integral membrane protein Caveolin-1 (Cav-1) has been suggested as a potent target in human pancreatic carcinoma cells.
MATERIALS AND METHODS: Human pancreatic tumor cells were examined in a three-dimensional (3D) cell culture model with regard to clonogenic survival, apoptosis, radiogenic DNA-double strand breaks and protein expression and phosphorylation under siRNA-mediated knockdown of Cav-1 without and in combination with irradiation (X-rays, 0-6Gy). Immunohistochemistry was used to assess Cav-1 expression in biopsies from patients with PDAC.
RESULTS: Tumor cells in PDAC showed significantly higher Cav-1 expression relative to tumor stroma. Cav-1 knockdown significantly reduced beta1 integrin expression and Akt phosphorylation, induced Caspase 3- and Caspase 8-dependent apoptosis and enhanced the radiosensitivity of 3D cell cultures. While cell cycling and Cav-1 promoter activity remained stable, Cav-1 knockdown-induced radiosensitization correlated with elevated numbers of residual DNA-double strand breaks.
CONCLUSIONS: Our data strongly support the concept of Cav-1 as a potent target in pancreatic carcinoma cells due to radiosensitization and Cav-1 overexpression in tumor cells of PDAC. 3D cell cultures are powerful and useful tools for the testing of novel targeting strategies to optimize conventional radio- and chemotherapy regimes for PDAC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665245     DOI: 10.1016/j.radonc.2009.07.004

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  40 in total

1.  Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice.

Authors:  Altaf Mohammed; Li Qian; Naveena B Janakiram; Stan Lightfoot; Vernon E Steele; Chinthalapally V Rao
Journal:  Int J Cancer       Date:  2012-03-14       Impact factor: 7.396

2.  Caveolin-1: an essential modulator of cancer cell radio-and chemoresistance.

Authors:  Stephanie Hehlgans; Nils Cordes
Journal:  Am J Cancer Res       Date:  2011-03-20       Impact factor: 6.166

3.  Deletion of caveolin scaffolding domain alters cancer cell migration.

Authors:  Sunaho Okada; Sadaf A Raja; Jonathan Okerblom; Aayush Boddu; Yousuke Horikawa; Supriyo Ray; Hideshi Okada; Itta Kawamura; Yoshiteru Murofushi; Fiona Murray; Hemal H Patel
Journal:  Cell Cycle       Date:  2019-05-22       Impact factor: 4.534

Review 4.  The changing paradigm of tumour response to irradiation.

Authors:  Richard P Hill
Journal:  Br J Radiol       Date:  2016-08-02       Impact factor: 3.039

5.  Caveolin-1 regulates cell apoptosis and invasion ability in paclitaxel-induced multidrug-resistant A549 lung cancer cells.

Authors:  Fei Han; Long Zhang; Yongxin Zhou; Xianghua Yi
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 6.  Biological determinants of radioresistance and their remediation in pancreatic cancer.

Authors:  Parthasarathy Seshacharyulu; Michael J Baine; Joshua J Souchek; Melanie Menning; Sukhwinder Kaur; Ying Yan; Michel M Ouellette; Maneesh Jain; Chi Lin; Surinder K Batra
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-02-27       Impact factor: 10.680

7.  Caveolae-Mediated Endocytosis Is Critical for Albumin Cellular Uptake and Response to Albumin-Bound Chemotherapy.

Authors:  Moumita Chatterjee; Edgar Ben-Josef; Ryan Robb; Marall Vedaie; Star Seum; Krishnan Thirumoorthy; Kamalakannan Palanichamy; Matthew Harbrecht; Arnab Chakravarti; Terence M Williams
Journal:  Cancer Res       Date:  2017-09-18       Impact factor: 12.701

8.  A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis.

Authors:  Chen Huang; Zhengjun Qiu; Liwei Wang; Zhihai Peng; Zhiliang Jia; Craig D Logsdon; Xiangdong Le; Daoyan Wei; Suyun Huang; Keping Xie
Journal:  Cancer Res       Date:  2011-12-22       Impact factor: 12.701

9.  Mitotic arrest and slippage induced by pharmacological inhibition of Polo-like kinase 1.

Authors:  Monika Raab; Andrea Krämer; Stephanie Hehlgans; Mourad Sanhaji; Elisabeth Kurunci-Csacsko; Christina Dötsch; Gesine Bug; Oliver Ottmann; Sven Becker; Fiona Pachl; Bernhard Kuster; Klaus Strebhardt
Journal:  Mol Oncol       Date:  2014-08-11       Impact factor: 6.603

10.  Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling.

Authors:  Altaf Mohammed; Naveena B Janakiram; Venkateshwar Madka; Rebekah L Ritchie; Misty Brewer; Laura Biddick; Jagan Mohan R Patlolla; Michael Sadeghi; Stan Lightfoot; Vernon E Steele; Chinthalapally V Rao
Journal:  Cancer Prev Res (Phila)       Date:  2014-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.